Webinar

Harnessing AI to revolutionize pharmacovigilance signal management

Join our experts, Stephen Sun, VP of Pharmacovigilance, and Lin Li, Head of Clinical Statistics and Computational Biology, on January 28, 2026, as they discuss how AI and advanced analytics are transforming pharmacovigilance (PV) signal management by overcoming growing signal management challenges. Our pharmacovigilance and statistics experts will examine how new technologies can help identify meaningful signals amidst increasing volumes and noise, address causality uncertainties, and reduce manual, error-prone processes – freeing safety teams to focus on critical tasks.

Key learnings

  • Enhanced signal detection accuracy using Bayesian modeling, machine learning, and natural language processing (NLP).
  • Reduced manual workloads in signal validation and evaluation, saving time and costs.
  • Improved compliance, audit readiness, and decision-making through automation and data harmonization, while following “human-in-the-loop” best practices for oversight.
  • Accelerated identification of causal safety signals, enabling faster and more confident regulatory responses.

Siamo qui per aiutarti

Contatta il nostro team oggi stesso per saperne di più su come Cencora sta contribuendo a plasmare il futuro dell'assistenza sanitaria.

Risorse correlate

Articolo

Managing pharmacovigilance challenges in local markets
Scopri di più

Articolo

Navigating the complex field of radioligand therapy: Three key takeaways
Scopri di più

Articolo

Sfruttare l'intelligenza artificiale e l'analisi avanzata per rivoluzionare la gestione del segnale fotovoltaico
Scopri di più